You are here:
Two key factors set the GAVI Alliance apart from other actors in the field of international health aid:
In this section, we explain GAVI’s unique business model and the six ways it delivers "added value".
Donor and developing countries need to see proof of the value of new vaccines before investing.
Immunisation is a commitment for life that requires guaranteed, long-term funding.
Developing countries decide for themselves how best to use GAVI support for immunisation.
It's not enough to buy new vaccines. They have to safely reach every child.
Manufacturers will only make vaccines for poor countries if they know they can sell them .
National immunisation programes must survive long after GAVI support stops.
The Accelerated Vaccine Introduction Initiative is a showcase of the GAVI business model at work.
Since 2000, 440 million additional children have been immunised through GAVI support to routine immunisation in the world's poorest countries.
22 January 2014
The toll of the anti-vaccination movement, in one devastating graphic
Los Angeles Times
Public Health Officials Mark 50th Year of Measles Vaccine
02 October 2013
Laos becomes first South East Asian nation to introduce pneumococcal vaccine
04 May 2013
Sojo Stories: Immunizing 250 Million Children By 2015
27 March 2013
Seth Berkley on Immunization in Pakistan
Heartfile eForum Blog
05 October 2012
GAVI Alliance CEO: Leadership Is About Vision and Responsibility, Not Power
28 September 2012
Vaccines and Ensuring the Health of Children No Matter Where They Live
The Huffington Post
06 August 2012
GAVI looks forward to strengthening cooperation with China: CEO
06 July 2012
Dagfinn Høybråten: GAVI’s mission to help fulfill MDGs
14 June 2012
How vaccination can stop 1.7m children dying this year
© GAVI Alliance 2014
modal window here